These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 25801878)

  • 21. Characterization of T lymphocyte subpopulations responsible for deficient interleukin 2 activity in patients with systemic lupus erythematosus.
    Murakawa Y; Takada S; Ueda Y; Suzuki N; Hoshino T; Sakane T
    J Immunol; 1985 Jan; 134(1):187-95. PubMed ID: 3917275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus.
    Wong CK; Lit LC; Tam LS; Li EK; Lam CW
    Rheumatology (Oxford); 2005 Aug; 44(8):989-94. PubMed ID: 15870153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MAP4K Family Kinases and DUSP Family Phosphatases in T-Cell Signaling and Systemic Lupus Erythematosus.
    Chuang HC; Tan TH
    Cells; 2019 Nov; 8(11):. PubMed ID: 31766293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus.
    Liang B; Gardner DB; Griswold DE; Bugelski PJ; Song XY
    Immunology; 2006 Nov; 119(3):296-305. PubMed ID: 17067309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship.
    Wouters CH; Diegenant C; Ceuppens JL; Degreef H; Stevens EA
    Br J Dermatol; 2004 Apr; 150(4):693-700. PubMed ID: 15099365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulatory T cells in systemic lupus erythematosus.
    Ohl K; Tenbrock K
    Eur J Immunol; 2015 Feb; 45(2):344-55. PubMed ID: 25378177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reconstitution of deficient T cell receptor zeta chain restores T cell signaling and augments T cell receptor/CD3-induced interleukin-2 production in patients with systemic lupus erythematosus.
    Nambiar MP; Fisher CU; Warke VG; Krishnan S; Mitchell JP; Delaney N; Tsokos GC
    Arthritis Rheum; 2003 Jul; 48(7):1948-55. PubMed ID: 12847689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Progress of Investigating the CD137-CD137L Axis as a Potential Target for Systemic Lupus Erythematosus.
    Mak A; Schwarz H
    Cells; 2019 Sep; 8(9):. PubMed ID: 31500130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aberrant T Cell Signaling and Subsets in Systemic Lupus Erythematosus.
    Katsuyama T; Tsokos GC; Moulton VR
    Front Immunol; 2018; 9():1088. PubMed ID: 29868033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B cell hyperactivity is a function of T cell derived cytokines in systemic lupus erythematosus.
    al-Janadi M; Raziuddin S
    J Rheumatol; 1993 Nov; 20(11):1885-91. PubMed ID: 7508509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus.
    Kuhn A; Beissert S; Krammer PH
    Arch Dermatol Res; 2009 Jan; 301(1):71-81. PubMed ID: 18985367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Regulatory T-cells in systemic lupus erythematosus. IL-2 is decisive for loss of tolerance].
    Ohl K; Tenbrock K
    Z Rheumatol; 2016 Apr; 75(3):253-64. PubMed ID: 26975190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD8alpha+beta(low) effector T cells in systemic lupus erythematosus.
    Werwitzke S; Tiede A; Jacobs R; Zielinska-Skowronek M; Buyny S; Schmidt RE; Witte T
    Scand J Immunol; 2008 May; 67(5):501-8. PubMed ID: 18405327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The immunological basis of B-cell therapy in systemic lupus erythematosus.
    Mok MY
    Int J Rheum Dis; 2010 Feb; 13(1):3-11. PubMed ID: 20374380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alterations in T-lymphocyte sub-set profiles and cytokine secretion by PBMC of systemic lupus erythematosus patients upon in vitro exposure to organochlorine pesticides.
    Dar SA; Das S; Ramachandran VG; Bhattacharya SN; Mustafa MD; Banerjee BD; Verma P
    J Immunotoxicol; 2012; 9(1):85-95. PubMed ID: 22214240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Role of γδ T Cells in Systemic Lupus Erythematosus.
    Wu M; Yang J; Li X; Chen J
    J Immunol Res; 2016; 2016():2932531. PubMed ID: 26981547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative and qualitative analysis of the balance between type 1 and type 2 cytokine-producing CD8(-) and CD8(+) T cells in systemic lupus erythematosus.
    Amel-Kashipaz MR; Huggins ML; Lanyon P; Robins A; Todd I; Powell RJ
    J Autoimmun; 2001 Sep; 17(2):155-63. PubMed ID: 11591124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered signal transduction in SLE T cells.
    Tenbrock K; Juang YT; Kyttaris VC; Tsokos GC
    Rheumatology (Oxford); 2007 Oct; 46(10):1525-30. PubMed ID: 17586862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T cells in the pathogenesis of systemic lupus erythematosus.
    Hoffman RW
    Clin Immunol; 2004 Oct; 113(1):4-13. PubMed ID: 15380523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contribution of dendritic cells to the autoimmune pathology of systemic lupus erythematosus.
    Mackern-Oberti JP; Llanos C; Riedel CA; Bueno SM; Kalergis AM
    Immunology; 2015 Dec; 146(4):497-507. PubMed ID: 26173489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.